The El Paso investigators said they initiated their research to move beyond smaller studies because the real-world impact of GLP-1 RA on multiple co-occurrence of SUD (substance use disorder) has not been systematically investigated. To address this gap, the team conducted a retrospective nested case-control study using data from the NIHs All of Us Research Program
View study Xiong Y, Mahmood A, Meng Y, et al
Immune Defic
The Three Delivery Methods: How They Compare Injectable GLP-1s (Weekly Injections) Injectable medications are delivered directly into subcutaneous tissue, providing nearly 100% bioavailability
Lower estrogen, reduced activity over time, and menopause-related sleep disruption often work together to drive steady weight gainabout 1.5 pounds per year on average after menopause
AOD-9604, a synthetic growth hormone analogue, has been studied as an investigational agent for several indications 1